• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突尼斯斯法克斯重症 COVID-19 患者的临床特征与预后

Clinical characteristics and outcomes of critically ill COVID-19 patients in Sfax, Tunisia.

作者信息

Bahloul Mabrouk, Kharrat Sana, Chtara Kamilia, Hafdhi Malek, Turki Olfa, Baccouche Najeh, Ammar Rania, Kallel Nozha, Hsairi Majdi, Chakroun-Walha Olfa, Hamida Chokri Ben, Chelly Hedi, Mahfoudh Khaiereddine Ben, Karoui Abelhamid, Karray Hela, Rekik Noureddine, Bouaziz Mounir

机构信息

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax University, Sfax, Tunisia.

Department of Radiology, Habib Bourguiba University Hospital, Sfax University, Sfax, Tunisia.

出版信息

Acute Crit Care. 2022 Feb;37(1):84-93. doi: 10.4266/acc.2021.00129. Epub 2021 Nov 16.

DOI:10.4266/acc.2021.00129
PMID:34380191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8918704/
Abstract

BACKGROUND

Africa, like the rest of the world, has been impacted by the coronavirus disease 2019 (COVID-19) pandemic. However, only a few studies covering this subject in Africa have been published.

METHODS

We conducted a retrospective study of critically ill adult COVID-19 patients-all of whom had a confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection- admitted to the intensive care unit (ICU) of Habib Bourguiba University Hospital (Sfax, Tunisia).

RESULTS

A total of 96 patients were admitted into our ICU for respiratory distress due to COVID-19 infection. Mean age was 62.4±12.8 years and median age was 64 years. Mean arterial oxygen tension (PaO2)/fractional inspired oxygen (FiO2) ratio was 105±60 and ≤300 in all cases but one. Oxygen support was required for all patients (100%) and invasive mechanical ventilation for 38 (40%). Prone positioning was applied in 67 patients (70%). Within the study period, 47 of the 96 patients died (49%). Multivariate analysis showed that the factors associated with poor outcome were the development of acute renal failure (odds ratio [OR], 6.7; 95% confidence interval [CI], 1.75-25.9), the use of mechanical ventilation (OR, 5.8; 95% CI, 1.54-22.0), and serum cholinesterase (SChE) activity lower than 5,000 UI/L (OR, 5.0; 95% CI, 1.34-19).

CONCLUSIONS

In this retrospective cohort study of critically ill patients admitted to the ICU in Sfax, Tunisia, for acute respiratory failure following COVID-19 infection, the mortality rate was high. The development of acute renal failure, the use of mechanical ventilation, and SChE activity lower than 5,000 UI/L were associated with a poor outcome.

摘要

背景

与世界其他地区一样,非洲也受到了2019冠状病毒病(COVID-19)大流行的影响。然而,在非洲,仅有少数关于该主题的研究发表。

方法

我们对入住哈比卜·布尔吉巴大学医院(突尼斯斯法克斯)重症监护病房的成年COVID-19危重症患者进行了一项回顾性研究,所有患者均确诊感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。

结果

共有96例因COVID-19感染导致呼吸窘迫的患者入住我们的重症监护病房。平均年龄为62.4±12.8岁,中位年龄为64岁。除1例患者外,所有患者的平均动脉血氧分压(PaO2)/吸入氧分数(FiO2)比值为105±60且≤300。所有患者(100%)均需要氧疗,38例(40%)需要有创机械通气。67例患者(70%)采用了俯卧位通气。在研究期间,96例患者中有47例死亡(49%)。多因素分析显示,与预后不良相关的因素包括急性肾衰竭的发生(比值比[OR],6.7;95%置信区间[CI],1.75-25.9)、机械通气的使用(OR,5.8;95%CI,1.54-22.0)以及血清胆碱酯酶(SChE)活性低于5000 UI/L(OR,5.0;95%CI,1.34-19)。

结论

在这项对突尼斯斯法克斯因COVID-19感染后急性呼吸衰竭入住重症监护病房的危重症患者的回顾性队列研究中,死亡率很高。急性肾衰竭的发生、机械通气的使用以及SChE活性低于5000 UI/L与预后不良相关。

相似文献

1
Clinical characteristics and outcomes of critically ill COVID-19 patients in Sfax, Tunisia.突尼斯斯法克斯重症 COVID-19 患者的临床特征与预后
Acute Crit Care. 2022 Feb;37(1):84-93. doi: 10.4266/acc.2021.00129. Epub 2021 Nov 16.
2
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
3
Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.在高流量氧疗或无创通气期间急性呼吸窘迫综合征标准的局限性:来自危重症 COVID-19 患者的证据。
Crit Care. 2022 Mar 7;26(1):55. doi: 10.1186/s13054-022-03933-1.
4
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.阿根廷 COVID-19 有创通气患者的临床特征和结局(SATICOVID):一项前瞻性、多中心队列研究。
Lancet Respir Med. 2021 Sep;9(9):989-998. doi: 10.1016/S2213-2600(21)00229-0. Epub 2021 Jul 2.
5
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
6
Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19-A Retrospective Study.新冠重症患者重症监护病房心脏骤停的特征与危险因素——一项回顾性研究
J Clin Med. 2021 May 19;10(10):2195. doi: 10.3390/jcm10102195.
7
Severe Acute Kidney Injury in Critically Ill Patients with COVID-19 Admitted to ICU: Incidence, Risk Factors, and Outcomes.入住重症监护病房的 COVID-19 危重症患者的严重急性肾损伤:发病率、危险因素及预后
J Clin Med. 2021 Mar 15;10(6):1217. doi: 10.3390/jcm10061217.
8
Prognostic Value of Serum Cholinesterase Activity in Severe SARS-CoV-2-Infected Patients Requiring Intensive Care Unit Admission.血清胆碱酯酶活性在需要入住重症监护病房的重症新型冠状病毒肺炎感染患者中的预后价值
Am J Trop Med Hyg. 2022 Jul 25;107(3):534-9. doi: 10.4269/ajtmh.21-0934.
9
Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study.352 例 COVID-19 危重症患者 28 天病死率的临床特征及其预测因素:一项回顾性研究。
J Epidemiol Glob Health. 2021 Mar;11(1):98-104. doi: 10.2991/jegh.k.200928.001. Epub 2020 Oct 3.
10
Outcomes of patients with COVID-19 acute respiratory distress syndrome requiring invasive mechanical ventilation admitted to an intensive care unit in South Africa.南非重症监护病房中需要有创机械通气的 COVID-19 急性呼吸窘迫综合征患者的结局。
S Afr Med J. 2022 Feb 2;112(1):13516.

引用本文的文献

1
Serum butyrylcholinesterase activity as a predictor of severity and mortality in COVID-19 patients.血清丁酰胆碱酯酶活性作为COVID-19患者严重程度和死亡率的预测指标
Sci Rep. 2025 Jul 2;15(1):23437. doi: 10.1038/s41598-025-07017-2.
2
Breaking new ground: machine learning enhances survival forecasts in hypercapnic respiratory failure.开辟新天地:机器学习改善高碳酸血症性呼吸衰竭的生存预测
Front Med (Lausanne). 2025 Feb 20;12:1497651. doi: 10.3389/fmed.2025.1497651. eCollection 2025.
3
Laboratory findings predictive of critical illness in hospitalized COVID-19 patients in Tunisia.

本文引用的文献

1
Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.SARS-CoV-2 与其他病原体合并感染和继发感染的流行率和结局:系统评价和荟萃分析。
PLoS One. 2021 May 6;16(5):e0251170. doi: 10.1371/journal.pone.0251170. eCollection 2021.
2
Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area.多伦多地区因 COVID-19 和流感住院的特征和结果。
CMAJ. 2021 Mar 22;193(12):E410-E418. doi: 10.1503/cmaj.202795. Epub 2021 Feb 10.
3
Clinical characteristics of 4499 COVID-19 patients in Africa: A meta-analysis.
突尼斯住院COVID-19患者中预测危重症的实验室检查结果。
F1000Res. 2024 Nov 18;13:918. doi: 10.12688/f1000research.151333.2. eCollection 2024.
4
Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study.血清丁酰胆碱酯酶作为 COVID-19 死亡率的标志物:一项单中心前瞻性观察研究的结果。
Chem Biol Interact. 2023 Aug 25;381:110557. doi: 10.1016/j.cbi.2023.110557. Epub 2023 May 19.
5
Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania.坦桑尼亚新冠肺炎危重症患者护理策略的成本效益
Pharmacoecon Open. 2023 Jul;7(4):537-552. doi: 10.1007/s41669-023-00418-x. Epub 2023 May 13.
6
Prognostic Value of Serum Cholinesterase Activity in Severe SARS-CoV-2-Infected Patients Requiring Intensive Care Unit Admission.血清胆碱酯酶活性在需要入住重症监护病房的重症新型冠状病毒肺炎感染患者中的预后价值
Am J Trop Med Hyg. 2022 Jul 25;107(3):534-9. doi: 10.4269/ajtmh.21-0934.
非洲 4499 例 COVID-19 患者的临床特征:一项荟萃分析。
J Med Virol. 2021 May;93(5):3055-3061. doi: 10.1002/jmv.26848. Epub 2021 Feb 12.
4
Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome.与 COVID-19 相关的医院感染:重症监护病房的临床特征和结局。
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):495-502. doi: 10.1007/s10096-020-04142-w. Epub 2021 Jan 3.
5
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.药物干预治疗 COVID-19 的疗效和安全性比较:系统评价和网络荟萃分析。
PLoS Med. 2020 Dec 30;17(12):e1003501. doi: 10.1371/journal.pmed.1003501. eCollection 2020 Dec.
6
Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients.慢性肾脏病或急性肾损伤与 COVID-19 患者临床结局的关联。
J Korean Med Sci. 2020 Dec 28;35(50):e434. doi: 10.3346/jkms.2020.35.e434.
7
Mortality of patients with COVID-19 who undergo an elective or emergency surgical procedure: a systematic review and meta-analysis.COVID-19 患者行择期或急诊手术的死亡率:系统评价和荟萃分析。
ANZ J Surg. 2021 Jan;91(1-2):33-41. doi: 10.1111/ans.16500. Epub 2020 Dec 27.
8
Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity.锌、维生素D和维生素C:聚焦物理组织屏障完整性的COVID-19研究视角
Front Nutr. 2020 Dec 7;7:606398. doi: 10.3389/fnut.2020.606398. eCollection 2020.
9
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review.COVID-19感染的诊断与住院管理的多学科方法:一项叙述性综述
Front Pharmacol. 2020 Dec 9;11:572168. doi: 10.3389/fphar.2020.572168. eCollection 2020.
10
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.刚果民主共和国金沙萨尼加利马公立医院住院的 COVID-19 患者的临床特征:一项回顾性队列研究。
PLoS One. 2020 Dec 18;15(12):e0244272. doi: 10.1371/journal.pone.0244272. eCollection 2020.